{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:42Z","timestamp":1786986882236,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.clinthera.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T04:59:22Z","timestamp":1280984362000},"page":"1294-1303","source":"Crossref","is-referenced-by-count":6,"title":["Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan"],"prefix":"10.1016","volume":"32","author":[{"given":"Kuo-Wei","family":"Hsiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tseng-Shing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiing-Chyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Full-Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2010.07.005_bib1","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1007\/s10067-006-0203-8","article-title":"Update on guidelines for the treatment of chronic musculoskeletal pain","volume":"25","author":"Schnitzer","year":"2006","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.clinthera.2010.07.005_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage."},{"key":"10.1016\/j.clinthera.2010.07.005_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.clinthera.2009.04.012","article-title":"Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing","volume":"31","author":"Barozzi","year":"2009","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.07.005_bib4","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.clinthera.2007.11.012","article-title":"Acute NSAID-related transmural duodenitis and extensive duodenal ulceration","volume":"29","author":"Hashash","year":"2007","journal-title":"Clin Ther."},{"key":"10.1016\/j.clinthera.2010.07.005_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/0003-4819-115-10-787","article-title":"Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis","volume":"115","author":"Gabriel","year":"1991","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2004.01935.x","article-title":"Review article: Prevention of nonsteroidal anti-inflammatory drug gastrointestinal complications-review and recommendations based on risk assessment","volume":"19","author":"Chan","year":"2004","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.07.005_bib7","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","article-title":"Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomized double-blind comparison","volume":"354","author":"Emery","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2010.07.005_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D","article-title":"Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial","volume":"43","author":"Hawkey","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clinthera.2010.07.005_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cgh.2007.03.011","article-title":"Gastrointestinal safety of cyclooxygenase-2 inhibitors: A Cochrane Collaboration systematic review","volume":"5","author":"Rostom","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.clinthera.2010.07.005_bib10","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.gastro.2004.07.010","article-title":"Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial","volume":"127","author":"Chan","year":"2004","journal-title":"Gastroenterology."},{"key":"10.1016\/j.clinthera.2010.07.005_bib12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.amjmed.2005.04.031","article-title":"Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications","volume":"118","author":"Lai","year":"2005","journal-title":"Am J Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.gie.2009.01.041","article-title":"Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities","volume":"70","author":"Cheng","year":"2009","journal-title":"Gastrointest Endosc."},{"key":"10.1016\/j.clinthera.2010.07.005_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1365-2036.2002.01279.x","article-title":"The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment","volume":"16","author":"Luo","year":"2002","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.07.005_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2125.2009.03445.x","article-title":"Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy","volume":"68","author":"Luo","year":"2009","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.clinthera.2010.07.005_bib16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2036.2003.01418.x","article-title":"Occurrence of peptic ulcer disease in connective tissue disease patients associated with xerostomia","volume":"17","author":"Luo","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.clinthera.2010.07.005_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Longterm Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.clinthera.2010.07.005_bib19","first-page":"140","article-title":"An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference [published corrections appear in J Rheumatol. 2006;33:440 and J Rheumatol. 2006;33:829]","volume":"33","author":"Tannenbaum","year":"2006","journal-title":"J Rheumatol."},{"key":"10.1016\/j.clinthera.2010.07.005_bib20","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1111\/j.1572-0241.2008.02200.x","article-title":"Management of patients on non-steroidal anti-inflammatory drugs: A clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents","volume":"103","author":"Chan","year":"2008","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.clinthera.2010.07.005_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Hawkey","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs","volume":"338","author":"Yeomans","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2010.07.005_bib23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1365-2036.2005.02444.x","article-title":"Meta-analysis: Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users","volume":"21","author":"Vergara","year":"2005","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291810002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T20:30:48Z","timestamp":1544301048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291810002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0149291810002328"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2010.07.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}